Michael D. Lesh, Sm Md Facc Email & Phone Number

Physicians have been weighed down by ballooning administrative demands rather than focusing on patient care. New technologies, marketed under the guise of "efficiency", accentuate physician burden rather than alleviating it. At Quench, we are leveraging generative AI to revolutionize provider workflow. SmartChart uses our proprietary gen AI to simplify and expedite the burdensome process of reviewing medical records, which often arrive as 1000's of pages of disorganized PDF. SmartChart is indispensable for physicians (IME) called upon to evaluate workers' compensation claims, compliance with standard of care, and injury by defective products; as well as for law firms and insurance companies that scrutinize medical records in litigation, claims disputes or underwriting.

San Francisco, Ca, Us

Syntegra uses generative AI to create synthetic healthcare data to enable privacy-preserved access to high fidelity patient level data.

Boston, Massachusetts, Us

ElucidVivo™ PlaqueIQ FDA-cleared, non-invasive AI-based analysis software providing unprecedented specificity of plaque stability and vessel structure; and ElucidVivo™ FFRCT + PlaqueIQCombination of plaque analysis and FFR for a more direct measure of stress induced ischemia of coronary and carotid arteries.

Mountain View, California, Us

Cordance is revolutionizing treatment of cancer, Alzheimer's disease, and other brain disorders using non-invasive transcranial focused ultrasound to temporarily open the blood-brain-barrier.

San Francisco, California, Us

San Francisco, California, Us

San Francisco, California, Us

The VizaraMed Multiflex Steerable Sheath is a novel approach to precise placement of catheters and implants in the left atrium.

Novel urine diagnostic to assess kidney function that could revolutionize heart failure treatment. Founded by noted UCSF nephrologists, Michelle Estrella, MD MHS and Michael Shlipak, MD MPH

San Francisco , Us

Palo Alto, California, Us

Novel percutaneous implant to treat mitral regurgitation of any cause, without open heart surgery.Acquired by Symetis SA February 2017

Digital health system for early diagnosis of heart attacks. Acquired by Roper Industries.

Novel non-contracting material for plastic and reconstructive surgery

Developed first percutaneous left atrial appendage occlusion (LAAO) device to prevent stroke in patients with atrial fibrillation, obviating the need for long-term anticoagulation.Acquired by eV3 (Medtronic)

World's first percutaneous mitral valve technology. Intended to treat heart valve disease without heart surgery.Acquired by eV3 (Medtronic)

Invented: Method of Pulmonary Vein Isolation;Ultrasound balloon device for catheter ablation of atrial fibrillation.Acquired by Johnson and Johnson

San Francisco, California, Us

San Francisco, California, Us

San Francisco, California, Us

S.B. & S.M., Computer Science & Biomedical Engineering

Doctor Of Medicine (Md)

Resident, Internal Medicine

Fellow, Cardiology And Cardiac Electrophysiology